Abstract
Neural stem cells (NSC) are cells that have the capacity to generate multiple types of differentiated brain cells. In conditions in which there is a loss of key functional cell groups, such as neurons, inducing or introducing neural stem cells to replace the function of those cells that were lost during the disease has the greatest potential therapeutic applications. Indeed, the achievement of one of the main objectives of various investigations is already on the horizon for some conditions, such as Alzheimers disease. It is not known whether impaired neurogenesis contributes to neuronal depletion and cognitive dysfunction in Alzheimers disease (AD). The results of the different investigations are controversial; some studies have found that neurogenesis is increased in AD brains, but others have not.
Keywords: Neurodegenerative disease, Alzheimer's Disease, neurogenesis, neural stem cells, cell death, pEGFR, EGFR, Endocytosis, Gefitinib, Endosomes, Lysosomes, Nucleus, NSCLC
Current Signal Transduction Therapy
Title: Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?
Volume: 6 Issue: 3
Author(s): Rocio E. Gonzalez-Castaneda, Alma Y. Galvez-Contreras, Sonia Luquin and Oscar Gonzalez-Perez
Affiliation:
Keywords: Neurodegenerative disease, Alzheimer's Disease, neurogenesis, neural stem cells, cell death, pEGFR, EGFR, Endocytosis, Gefitinib, Endosomes, Lysosomes, Nucleus, NSCLC
Abstract: Neural stem cells (NSC) are cells that have the capacity to generate multiple types of differentiated brain cells. In conditions in which there is a loss of key functional cell groups, such as neurons, inducing or introducing neural stem cells to replace the function of those cells that were lost during the disease has the greatest potential therapeutic applications. Indeed, the achievement of one of the main objectives of various investigations is already on the horizon for some conditions, such as Alzheimers disease. It is not known whether impaired neurogenesis contributes to neuronal depletion and cognitive dysfunction in Alzheimers disease (AD). The results of the different investigations are controversial; some studies have found that neurogenesis is increased in AD brains, but others have not.
Export Options
About this article
Cite this article as:
E. Gonzalez-Castaneda Rocio, Y. Galvez-Contreras Alma, Luquin Sonia and Gonzalez-Perez Oscar, Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?, Current Signal Transduction Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157436211797483949
DOI https://dx.doi.org/10.2174/157436211797483949 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Anti-Cancer Agents in Medicinal Chemistry The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Seocalcitol (EB 1089) A Vitamin D Analogue of Anti-cancer Potential. Background, Design, Synthesis, Pre-clinical and Clinical Evaluation
Current Pharmaceutical Design Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Current Pharmaceutical Design A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Current Cancer Drug Targets Insertional Mutagenesis by Retroviral Vectors: Current Concepts and Methods of Analysis
Current Gene Therapy Current and Future Drug Treatments for Glioblastomas
Current Medicinal Chemistry PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery Anal Cancer: Focus on HIV-Positive Patients in the HAART Era
Current HIV Research c-Myc: Linking Transformation and Genomic Instability
Current Molecular Medicine Molecular Mechanism of Aniline Induced Spleen Toxicity and Neuron Toxicity in Experimental Rat Exposure: A Review
Current Neuropharmacology mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Antitumor Activity of Novel Benzensulfonamide Derivatives in View of their Physiochemical Properties Searched by Principal Component Analysis
Medicinal Chemistry Recent Patents on MicroRNA-Induced Pluripotent Stem Cell Generation
Recent Patents on Regenerative Medicine Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets
Current Cancer Drug Targets The Role of Cellular Senescence During Vascular Calcification: A Key Paradigm in Aging Research
Current Aging Science